These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 18980969)

  • 1. Targeting the PI3K p110alpha isoform inhibits medulloblastoma proliferation, chemoresistance, and migration.
    Guerreiro AS; Fattet S; Fischer B; Shalaby T; Jackson SP; Schoenwaelder SM; Grotzer MA; Delattre O; Arcaro A
    Clin Cancer Res; 2008 Nov; 14(21):6761-9. PubMed ID: 18980969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cells.
    Boller D; Schramm A; Doepfner KT; Shalaby T; von Bueren AO; Eggert A; Grotzer MA; Arcaro A
    Clin Cancer Res; 2008 Feb; 14(4):1172-81. PubMed ID: 18281552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.
    Billottet C; Banerjee L; Vanhaesebroeck B; Khwaja A
    Cancer Res; 2009 Feb; 69(3):1027-36. PubMed ID: 19176369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of class II phosphoinositide 3-kinase alpha expression below a critical threshold induces apoptotic cell death.
    Elis W; Triantafellow E; Wolters NM; Sian KR; Caponigro G; Borawski J; Gaither LA; Murphy LO; Finan PM; Mackeigan JP
    Mol Cancer Res; 2008 Apr; 6(4):614-23. PubMed ID: 18403640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sensitized RNA interference screen identifies a novel role for the PI3K p110γ isoform in medulloblastoma cell proliferation and chemoresistance.
    Guerreiro AS; Fattet S; Kulesza DW; Atamer A; Elsing AN; Shalaby T; Jackson SP; Schoenwaelder SM; Grotzer MA; Delattre O; Arcaro A
    Mol Cancer Res; 2011 Jul; 9(7):925-35. PubMed ID: 21652733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
    Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH
    Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110delta.
    Sawyer C; Sturge J; Bennett DC; O'Hare MJ; Allen WE; Bain J; Jones GE; Vanhaesebroeck B
    Cancer Res; 2003 Apr; 63(7):1667-75. PubMed ID: 12670921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The catalytic class I(A) PI3K isoforms play divergent roles in breast cancer cell migration.
    De Laurentiis A; Pardo OE; Palamidessi A; Jackson SP; Schoenwaelder SM; Reichmann E; Scita G; Arcaro A
    Cell Signal; 2011 Mar; 23(3):529-41. PubMed ID: 21056654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of PI 3-kinase p110beta in AKT signally, cell survival, and proliferation in human prostate cancer cells.
    Hill KM; Kalifa S; Das JR; Bhatti T; Gay M; Williams D; Taliferro-Smith L; De Marzo AM
    Prostate; 2010 May; 70(7):755-64. PubMed ID: 20058239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both p110alpha and p110beta isoforms of phosphatidylinositol 3-OH-kinase are required for insulin signalling in the hypothalamus.
    Tups A; Anderson GM; Rizwan M; Augustine RA; Chaussade C; Shepherd PR; Grattan DR
    J Neuroendocrinol; 2010 Jun; 22(6):534-42. PubMed ID: 20236230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the phosphatidylinositol-3 kinase/Akt pathway for the treatment of cancer.
    Kim D; Cheng GZ; Lindsley CW; Yang H; Cheng JQ
    Curr Opin Investig Drugs; 2005 Dec; 6(12):1250-8. PubMed ID: 16370391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A specific function for phosphatidylinositol 3-kinase alpha (p85alpha-p110alpha) in cell survival and for phosphatidylinositol 3-kinase beta (p85alpha-p110beta) in de novo DNA synthesis of human colon carcinoma cells.
    Bénistant C; Chapuis H; Roche S
    Oncogene; 2000 Oct; 19(44):5083-90. PubMed ID: 11042696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI3K p110beta positively regulates lipopolysaccharide-induced IL-12 production in human macrophages and dendritic cells and JNK1 plays a novel role.
    Utsugi M; Dobashi K; Ono A; Ishizuka T; Matsuzaki S; Hisada T; Shimizu Y; Kawata T; Aoki H; Kamide Y; Mori M
    J Immunol; 2009 May; 182(9):5225-31. PubMed ID: 19380768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting class IA PI3K isoforms selectively impairs cell growth, survival, and migration in glioblastoma.
    Höland K; Boller D; Hagel C; Dolski S; Treszl A; Pardo OE; Cwiek P; Salm F; Leni Z; Shepherd PR; Styp-Rekowska B; Djonov V; von Bueren AO; Frei K; Arcaro A
    PLoS One; 2014; 9(4):e94132. PubMed ID: 24718026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA interference-mediated silencing of the phosphatidylinositol 3-kinase catalytic subunit attenuates growth of human ovarian cancer cells in vitroand in vivo.
    Zhang X; Deng HX; Zhao X; Su D; Chen XC; Chen LJ; Wei YQ; Zhong Q; Li ZY; He X; Yi T
    Oncology; 2009; 77(1):22-32. PubMed ID: 19440000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A selective inhibitor of the p110delta isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16.
    Billottet C; Grandage VL; Gale RE; Quattropani A; Rommel C; Vanhaesebroeck B; Khwaja A
    Oncogene; 2006 Oct; 25(50):6648-59. PubMed ID: 16702948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of PI3K/Akt partially leads to the inhibition of PrP(C)-induced drug resistance in gastric cancer cells.
    Liang J; Ge F; Guo C; Luo G; Wang X; Han G; Zhang D; Wang J; Li K; Pan Y; Yao L; Yin Z; Guo X; Wu K; Ding J; Fan D
    FEBS J; 2009 Feb; 276(3):685-94. PubMed ID: 19143835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Phosphoinositide 3-Kinase p110α Isoform Regulates Leukemia Inhibitory Factor Receptor Expression via c-Myc and miR-125b to Promote Cell Proliferation in Medulloblastoma.
    Salm F; Dimitrova V; von Bueren AO; Ćwiek P; Rehrauer H; Djonov V; Anderle P; Arcaro A
    PLoS One; 2015; 10(4):e0123958. PubMed ID: 25915540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating the role of class-IA PI 3-kinase isoforms in adipocyte differentiation.
    Kim JE; Shepherd PR; Chaussade C
    Biochem Biophys Res Commun; 2009 Feb; 379(4):830-4. PubMed ID: 19114029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of PI3K class IA isoforms with regulatory subunit p55alpha using a scintillation proximity assay.
    Van Aller GS; Carson JD; Fernandes C; Lehr R; Sinnamon RH; Kirkpatrick RB; Tummino PJ; Luo L
    Anal Biochem; 2008 Dec; 383(2):311-5. PubMed ID: 18814837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.